Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
Prospective study of neuropsychiatric events in systemic lupus erythematosus
Journal of Rheumatology, 07/02/09
Hanly JG et al. – The association of lower health-related quality of life (HRQOL) with neuropsychiatric (NP) events over time, independent of progression in cumulative organ damage, emphasizes the persistent negative effect of NP events for pts with systemic lupus erythematosus (SLE).
Methods- Prospective study of NP events and their association with HRQOL over time in SLE pts
- Observational cohort study from single academic center for NP events and their attribution at enrollment and at annual assessments for up to 7 yrs
- NP events characterized by American College of Rheumatology case definitions
- Other variables: global SLE disease activity and cumulative organ damage
- Outcomes of NP events recorded and self-report HRQOL measured by mental (MCS) and physical (PCS) component summary scores of Medical Outcomes Study Short Form-36
- Of 209 pts: 88% female; 92% Caucasian, mean (SD) age 43.7 (13.8) yrs
- Follow-up for 175/209 (84%) pts
- Over mean follow-up of 3.6 (2.5) yrs, 299 NP events in 132/209 (63%) pts
- NP events attributed to SLE: 31% in 54 pts
- On multivariate analysis, lower MCS scores in pts with NP events vs those without events regardless of attribution
- Group means for PCS scores significantly lower in pts with NP events regardless of attribution
- No association between HRQOL and cumulative organ damage nor between NP events and organ damage progression
Today in Anxiety...keeping you current
Receive free subspecialty "5-minute updates" via email
Estimation of clonazepam abuse liability: a new method using a reimbursed drug database
International Clinical Psychopharmacology, 10/20/09
An algorithm for the pharmacological treatment of depression
Acta Psychiatrica Scandinavica, 11/04/09
How adolescents who cut themselves differ from those who take overdoses
European Child and Adolescent Psychiatry, 10/05/09
Today in Mood Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Asenapine versus olanzapine in acute mania: a double-blind extension study
Bipolar Disorders, 10/22/09
Management of agitation and aggression associated with Alzheimers disease: controversies and possible solutions
Current Opinion in Psychiatry, 10/12/09
Does Dual Antidepressant Therapy as Initial Treatment Hasten and Increase Remission from Depression
Journal of Psychiatric Practice, 09/29/09
Today in Neuropsych Sciences...keeping you current
Receive free subspecialty "5-minute updates" via email
A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia
Journal of Psychopharmacology, 10/19/09
Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism
Journal of Psychopharmacology, 10/20/09
Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
Clinical Interventions in Aging, 09/29/09
Sponsor
Article Search
Sponsor


See Latest Articles


